Oct 22

‘Alarmingly’ few childhood cancer survivors undergo recommended surveillance for late effects

A high percentage of childhood survivors do not undergo guideline-recommended monitoring for late effects, according to results of a population-based study.

Comments

Tracing cancer back to birth uncovers promising biomarkers for prevention, targeted treatment of childhood leukemia

CRISPR Plus Drug Treatment Makes Neuroblastoma Responsive to Immunotherapy

Colorectal cancer cases on the rise in kids

New drug, WNTinib, delays tumor growth and improves survival in mouse models of children's liver cancer

First-of-their-kind findings turn conventional wisdom about diffuse hemispheric glioma on its head

Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye Cancer

‘Alarmingly’ few childhood cancer survivors undergo recommended surveillance for late effects

Survivors of childhood brain cancer are more likely to be held back in school

Gene therapy for fatal child brain disease may cause blood cancers

Children with aggressive blood cancer offered treatment cure hope

Recent Posts

‘Alarmingly’ few childhood cancer survivors undergo recommended surveillance for late effects

Comments

Archive

Search By Tags